Introduction
Adult-type hypolactasia (ATH, lactase non-persistence) is an autosomal recessive trait with ethnic and geographical variations in its prevalence and age at onset (Swallow, 2003; Rasinperä et al., 2004) . A single nucleotide polymorphism (SNP), upstream of the human lactase gene (Enattah et al., 2002) , has various enhancing effects on the lactase gene expression (Olds and Sibley, 2003; Lewinsky et al., 2005) . In individuals with T/T -13910 and C/T -13910 or with the C/C -13910 variant, lactase persistence or nonpersistence may develop, respectively. In Hungary, the standard method of ATH diagnosis is the lactose H 2 breath test (HBT). We determined the prevalence of lactasepersistent and non-persistent genotypes in the Hungarian population, and the age at onset of ATH, and compared the genotypes with the HBT in symptomatic and asymptomatic children.
Materials and methods
Three groups of 296 Caucasian-Hungarian individuals were analysed. Group 1 consisted of 82 persons (46 females, 36 males; mean age: 11 years; range: 2-19 years) with ATHrelated symptoms. In all, 15% of these subjects exhibited coeliac disease, 9% giardiasis, 3% inflammatory bowel disease and 7% bacterial or viral intestinal infection, whereas group 2 comprised 104 randomly-selected control individuals (58 females, 46 males; mean age: 11 years; range: 2-20 years) with no abdominal symptoms and no previous gastrointestinal diseases . Both groups underwent HBT and genetic screening. The allele frequencies were established from group 3, 110 randomly-selected volunteers (age: 19-26 years) .
HBT was performed after the ingestion of 1 g of lactose/ body weight kilogram (max. 50 g) in a 10% aqueous solution.
If a secondary lactase deficiency, such as coeliac disease, was suspected in the background of positive HBT results (X20 p.p.m. at 120 min after lactose load), despite the presence of lactase-persistent genotypes, small intestinal biopsies were obtained.
Coeliac disease was detected histologically from the intestinal samples of 12 patients who displayed seropositivity for IgA anti-endomysial antibodies and/or IgA anti-gliadin antibodies and tissue transglutaminase. The histological staging was carried out according to the Marsh system: type 1, 2, 3a, 3b or 3c (Oberhuber, 2000) .
DNA was extracted from hair roots or buccal smears, using the Chelex-based method (Walsh et al., 1991) . A restriction enzyme recognition site including, SNP, was introduced into the PCR product by using the derived cleaved amplified polymorphic sequence (dCAPS) method (dCAPS Finder 2.0 program, forward primer: 5 0 -GGCAATACAGATAAGATAATG GAG-3 0 ; reverse primer: 5 0 -CCTATCCTCGTGGAATGCAGG-3 0 ; mismatching nucleotide underlined). PCR amplification reactions accorded to the AmpliTaq Gold DNA Polymerase protocol (Applied Biosystems, California, USA). The 119 base pair (bp) PCR products were cleaved separately by NlaIV or HinfI endonucleases (Fermentas, Ontario, Canada) , which resulted in the case of the C allele in 96-, 23-bp-long, and in that of the T allele in 97-, 22-bp-long fragments, and were run on an 8% native polyacrylamide gel with 1 negative (no template) and 3 positive controls (CC, CT and TT À13910 ) and visualized by UV transillumination.
The PCR products of the subjects with discrepant genotype and phenotype results were sequenced to confirm or disprove the results of the restriction fragment length polymorphism (RFLP) and to discover other possible mutations in the background of the discrepancy. Sequencing was conducted under BigDyeTM Terminator Version 3.1 cycling conditions. The products were purified by ethanol precipitation and analysed on an Automatic Sequencer 3730xl (Applied Biosystems).
Statistical analysis
The GraphPad Prism version 4.00 for Windows software (GraphPad Software, San Diego, California, USA) was used. Parametric data were calculated by variance analysis and the unpaired Student's t-test with the Welch correction when the variances between the pairs of groups differed significantly (Po0.05 in the F-test). Data are expressed as means ± standard error of the mean (means ± s.e.m.). HBT results were compared with the genotype by the Fisher exact test. Po0.05 was considered to be statistically significant.
Results
The prevalences of the C/C À13910 , C/T À13910 and T/T À13910 genotypes were 73, 26 and 1% in group 1, as compared with 38, 50 and 12% in group 2, and 37, 48 and 15% in group 3. The allele frequencies associated with lactase persistence (T À13910 ) and non-persistence (C À13910 ) in group 3 were 37.8 and 62.2%, respectively.
The individuals of group 1 and 2 with different genotypes for the HBT were subdivided into three age groups to evaluate the age at onset (Table 1 ). In all, 12 patients had type 3 coeliac disease. Five of the 12 patients had the C/C À13910 genotype and 7 others had the C/T À13910 Table 1 Comparison of the C/T À13910 genotypes with the H 2 breath test results in the age-subgroups of patients (group 1) and controls (group 2) Coeliac disease was diagnosed in one subject aged 4 years (type 3b). f Adult-type hypolactasia-related symptoms were enhanced by intestinal infection. g The exhaled H 2 levels were close to the cut-off level (17-19 parts per million) in two cases in group 1 and in three cases in group 2.
Genotyping of lactase C/T -13910 variants D Nagy et al genotype. Among the patients with the C/C À13910 genotype, 1 (20%) had type 3a, 3 (60%) had type 3b and 1 (20%) had type 3c coeliac disease. One C/T À13910 genotyped patient had type 3a (14%), 4 had type 3b (57%) and 2 had type 3c (29%). Subjects with coeliac disease and negative HBT results were on a gluten-free diet.
A significant difference in the mean exhaled H 2 level was measured between groups 1 and 2 (Figure 1) . The 120-min sampling point of the HBT results proved to be the most reliable in comparison with the genotypes in groups 1 and 2, both in the 5-12-year (group 1: Po0.01, group 2: Po0.001) and in the 412-year subgroup (group 1: Po0.001, group 2: Po0.001). The positive and negative predictive values, and the sensitivity and specificity of the HBT at 120 min in groups 1 and 2, together with the results of previous studies, are presented in Table 2 .
Five of the 33 sequenced samples showed different results from those of RFLP. The correct C/T À13910 genotypes based on sequencing are presented in Table 1 .
Discussion
The 37% incidence of ATH in the Hungarian population corresponds to the overall level in Europe (Sahi, 1994) ; it is rarely manifested at o5 years. The coincidence of the C/C À13910 genotype with a positive HBT increases with age. The symptoms develop at around the age of 12 years; all those in group 1 aged 416 years had ATH-related symptoms, whereas in the control group the coincidence never reached 100%.
The C/C À13910 genotype displayed a close association with a positive HBT in group 1, whereas the lactase-persistent genotypes correlated better with a negative HBT in group 2. The patients had significantly higher H 2 levels than the controls from 60 min (Figure 1 ), presumably as a result of a lactase deficiency enhancement, primarily because of additional diseases that do not exist in group 2.
Despite introducing sequencing as an independent genotyping method, we were not able to clarify the discrepancies between the genotypes and the HBT results, except in 5 cases. The genotyping error rate of the RFLP in our study is Exhaled H 2 level [ppm] Figure 1 Means±s.e.m. lactose H 2 breath test data at 0, 30, 60, 90 and 120 min after lactose intake for the genotypes in the patients (group 1, n ¼ 82) and the controls (group 2, n ¼ 104). Asterisks denote significant differences (*Po0.05; **Po0.01) between the group 1 and 2 data. 15%, which is concordant with previous results (Hosking et al., 2004; Hüebner et al., 2007) . The discrepancy between the C/C À13910 genotype and the HBT results at 412 years may be explained by an abnormal colon bacterial metabolism or glucose metabolism, a slow intestinal transit or hypolactasia later in life.
The positive HBT results conflicting with the genotypes may be a consequence of accelerated intestinal transit, secondary lactose malabsorption because of inflammation, coeliac disease, giardiasis, bacterial or viral infections, a carrier status of a congenital lactase deficiency (Järvelä et al., 1998) or other genetic factors (Enattah et al., 2008) . Nevertheless, we were not able to detect any other SNP responsible for the ATH-related symptoms in the close vicinity of the C/T À13910 variant.
With regard to the sensitivity, specificity, and positive and negative predictive values of the HBT, our results correspond more or less to those in previous papers. The slight differences between our own and the previous data might be explained by the differences in the HBT methodology, the number, the nationality or the age of the subjects, and the analysis ( Table 2) .
The HBT has several disadvantages: it is time-consuming, a lactose intake may cause symptoms, physiological and pathological factors may influence the result and there can be a lack of distinction between primary and secondary lactose malabsorption. The DNA genotyping is exact, but provides no information on the manifestation of the symptoms after a lactose intake; it is suitable for the prediction of ATH even in childhood and for dietary intervention. We suggest a supplementary use of the two tests to achieve a correct diagnosis.
